Skip to main content
Erschienen in: Rheumatology International 11/2008

01.09.2008 | Case Report

Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy: case report and literature review

verfasst von: Ruo-Qi Hu, Hashim Mehter, Tibor Nadasdy, Anjali Satoskar, Dan N. Spetie, Brad H. Rovin, Lee Hebert

Erschienen in: Rheumatology International | Ausgabe 11/2008

Einloggen, um Zugang zu erhalten

Abstract

Severe hemorrhagic cystitis associated with oral cyclophosphamide (CYP) therapy has rarely been reported in the past 20 years, probably because this condition has largely disappeared because of the use of shorter courses of CYP, either oral or IV. Herein, we describe a patient who received 309 g of oral CYP over a 4-year period to treat Wegener’s granulomatosis (WG) that initially involved brain, lung, and kidney. She came under our care for the first time when she presented with a one-day history of oliguria and passing blood clots. Severe hemorrhagic cystitis was present. It eventually required cystectomy. Despite her massive CYP exposure her kidney biopsy showed acute crescentic glomerulonephritis. She survived her acute illness only to die 2 months later of acute leukemia. This patient is a reminder that severe hemorrhagic cystitis from oral CYP still exists, and that WG can be resistant to even toxic doses of oral CYP. Alternative therapies are discussed.
Literatur
1.
Zurück zum Zitat Watson NA, Notley RG (1973) Urological complications of cyclophosphamide. Br J Urol 45(6):606–609PubMedCrossRef Watson NA, Notley RG (1973) Urological complications of cyclophosphamide. Br J Urol 45(6):606–609PubMedCrossRef
2.
Zurück zum Zitat Hutter AM Jr, Bauman AW, Frank IN (1969) Cyclophosphamide and severe hemorrhagic cystitis. N Y State J Med 69(2):305–309PubMed Hutter AM Jr, Bauman AW, Frank IN (1969) Cyclophosphamide and severe hemorrhagic cystitis. N Y State J Med 69(2):305–309PubMed
3.
Zurück zum Zitat Bennett AH (1974) Cyclophosphamide and hemorrhagic cystitis. J Urol 111(5):603–606PubMed Bennett AH (1974) Cyclophosphamide and hemorrhagic cystitis. J Urol 111(5):603–606PubMed
4.
Zurück zum Zitat Stillwell TJ, Benson RC Jr, DeRemee RA, McDonald TJ, Weiland LH (1988) Cyclophosphamide-induced bladder toxicity in Wegener’s granulomatosis. Arthritis Rheum 31(4):465–470PubMedCrossRef Stillwell TJ, Benson RC Jr, DeRemee RA, McDonald TJ, Weiland LH (1988) Cyclophosphamide-induced bladder toxicity in Wegener’s granulomatosis. Arthritis Rheum 31(4):465–470PubMedCrossRef
5.
Zurück zum Zitat Langford CA (2003) Wegener’s granulomatosis: current and upcoming therapies. Arthritis Res Ther 5(4):180–191PubMedCrossRef Langford CA (2003) Wegener’s granulomatosis: current and upcoming therapies. Arthritis Res Ther 5(4):180–191PubMedCrossRef
6.
Zurück zum Zitat Schmitt WH, Hagen EC, Neumann I, Nowack R, Flores-Suarez LF, van der Woude FJ (2004) Treatment of refractory Wegener’s granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 65(4):1440–1448PubMedCrossRef Schmitt WH, Hagen EC, Neumann I, Nowack R, Flores-Suarez LF, van der Woude FJ (2004) Treatment of refractory Wegener’s granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 65(4):1440–1448PubMedCrossRef
7.
Zurück zum Zitat Christiansen DH, Andersen MK, Pedersen-Bjergaard J (2001) Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis. J Clin Oncol 19(5):1405–1413PubMed Christiansen DH, Andersen MK, Pedersen-Bjergaard J (2001) Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis. J Clin Oncol 19(5):1405–1413PubMed
8.
Zurück zum Zitat de Groot K, Adu D, Savage CO (2001) The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 16(10):2018–2027PubMedCrossRef de Groot K, Adu D, Savage CO (2001) The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 16(10):2018–2027PubMedCrossRef
9.
Zurück zum Zitat Nowack R, Gobel U, Klooker P, Hergesell O, Andrassy K, van der Woude FJ (1999) Mycophenolate mofetil for maintenance therapy of Wegener’s granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol 10(9):1965–1971PubMed Nowack R, Gobel U, Klooker P, Hergesell O, Andrassy K, van der Woude FJ (1999) Mycophenolate mofetil for maintenance therapy of Wegener’s granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol 10(9):1965–1971PubMed
10.
Zurück zum Zitat Eriksson P (2005) Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J Intern Med 257(6):540–548PubMedCrossRef Eriksson P (2005) Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J Intern Med 257(6):540–548PubMedCrossRef
11.
Zurück zum Zitat Specks U, Fervenza FC, McDonald TJ, Hogan MC (2001) Response of Wegener’s granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 44(12):2836–2840PubMedCrossRef Specks U, Fervenza FC, McDonald TJ, Hogan MC (2001) Response of Wegener’s granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 44(12):2836–2840PubMedCrossRef
12.
Zurück zum Zitat Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ (2003) Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 42(6):1149–1153PubMedCrossRef Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ (2003) Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 42(6):1149–1153PubMedCrossRef
13.
Zurück zum Zitat Garderet L, Bittencourt H, Sebe P et al (2000) Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients. Transplantation 70(12):1807–1811PubMedCrossRef Garderet L, Bittencourt H, Sebe P et al (2000) Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients. Transplantation 70(12):1807–1811PubMedCrossRef
14.
Zurück zum Zitat Chong KT, Corman JM (2005) Hemorrhagic cystitis. In: Wessells H, McAninch JW (eds) Urological emergencies: a practical guide. Humana Press Inc, Totowa, pp 201–212 Chong KT, Corman JM (2005) Hemorrhagic cystitis. In: Wessells H, McAninch JW (eds) Urological emergencies: a practical guide. Humana Press Inc, Totowa, pp 201–212
15.
Zurück zum Zitat Stillwell TJ, Benson RC Jr (1988) Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer 61(3):451–457PubMedCrossRef Stillwell TJ, Benson RC Jr (1988) Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer 61(3):451–457PubMedCrossRef
16.
Zurück zum Zitat Hughes MJ, Davis FM, Mark SD, Spearing RL (2002) Hyperbaric oxygen for cyclophosphamide-induced cystitis. Br J Haematol 119(2):575PubMedCrossRef Hughes MJ, Davis FM, Mark SD, Spearing RL (2002) Hyperbaric oxygen for cyclophosphamide-induced cystitis. Br J Haematol 119(2):575PubMedCrossRef
17.
Zurück zum Zitat Pauwels RP, Moonen WA (1970) Therapy in cytoxan hemorrhagic cystitis. Urol Int 25(2):187–195PubMedCrossRef Pauwels RP, Moonen WA (1970) Therapy in cytoxan hemorrhagic cystitis. Urol Int 25(2):187–195PubMedCrossRef
18.
Zurück zum Zitat Berkson BM, Lome LG, Shapiro I (1973) Severe cystitis induced by cyclophosphamide. Role of surgical management. Jama 225(6):605–606PubMedCrossRef Berkson BM, Lome LG, Shapiro I (1973) Severe cystitis induced by cyclophosphamide. Role of surgical management. Jama 225(6):605–606PubMedCrossRef
19.
Zurück zum Zitat Koc S, Hagglund H, Ireton RC, Perez-Simon JA, Collins SJ, Appelbaum FR (2000) Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 26(8):899–901PubMedCrossRef Koc S, Hagglund H, Ireton RC, Perez-Simon JA, Collins SJ, Appelbaum FR (2000) Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 26(8):899–901PubMedCrossRef
Metadaten
Titel
Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy: case report and literature review
verfasst von
Ruo-Qi Hu
Hashim Mehter
Tibor Nadasdy
Anjali Satoskar
Dan N. Spetie
Brad H. Rovin
Lee Hebert
Publikationsdatum
01.09.2008
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 11/2008
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0581-0

Weitere Artikel der Ausgabe 11/2008

Rheumatology International 11/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.